Microfluidic industry is well structured for growth
Yole Développement’s technology & market analysis, Microfluidic Applications in the Pharmaceutical, Life Sciences, In-Vitro Diagnostic and Medical Device Markets, provides a complete overview of the technology trends through a detailed marketing analysis.
By offering innovative solutions and cost advantages, microfluidic technologies are attracting more and more players from various fields. Under this context, numerous large companies are exploring the possibility of adopting microfluidics in order to improve their products.
Leveraging participation in major events and numerous interviews of microfluidic players performed by Yole’s analysts, the report consolidates 2012-2014 market data and proposes a high added-value analysis of the 2015-2020 forecasts.
With the healthcare industry moving steadily toward personalised medicine, technology has evolved to fit requirements. Consequently, significant improvements in drug discovery have been made thanks to breakthroughs in genomics. Moreover, the recent Ebola epidemic underlined the critical need for inexpensive tests to be rapidly analysed in the field in order to cure the sick as soon as possible. The push to avoid future epidemics will lead to many innovations in the microfluidic point-of-care field.
In the meantime, recent sanitary scandals have had for consequence the strengthening of regulations in the agro-food and water industries, thus sharply increasing the need for tests dedicated to bacteria detection. Industrial and environmental testing are thus in full swing, and are enjoying one of the best growth rates amongst microfluidic applications.
With a microfluidic devices market reaching $5.95bn in 2020 against $2.56bn in 2015, Yole’s analysts have confirmed: “Microfluidic applications are now well established and their advantages well-known.”